Aurinia will explore possible sale, following push by shareholder

Au­rinia Phar­ma­ceu­ti­cals said it will start ex­plor­ing strate­gic al­ter­na­tives, in­clud­ing a po­ten­tial sale. The an­nounce­ment fol­lows calls by one of its ma­jor share­hold­ers, MKT Cap­i­tal.

“The board will con­sid­er a wide range of op­tions for the com­pa­ny in­clud­ing, but not lim­it­ed to, a po­ten­tial sale, merg­er, or oth­er strate­gic trans­ac­tion,” Au­rinia said in a press re­lease Thurs­day. It al­so said that two board di­rec­tors, chair George Milne and Joseph Ha­gan, were re­sign­ing af­ter fail­ing to win ma­jor­i­ty sup­port from share­hold­ers.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN